Tandem Diabetes Care (TNDM) Gross Margin Growth (5y) (2018 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Tandem Diabetes Care | 1.31 Bn | 739.55 Mn | 136.79 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 337.00 |
| Dec 31, 2025 | 379.00 |
| Sep 30, 2025 | 104.00 |
| Jun 30, 2025 | 250.00 |
| Mar 31, 2025 | -82.00 |
| Dec 31, 2024 | 10.00 |
| Sep 30, 2024 | -245.00 |
| Jun 30, 2024 | -268.00 |
| Mar 31, 2024 | -115.00 |
| Dec 31, 2023 | -710.00 |
| Sep 30, 2023 | 124.00 |
| Jun 30, 2023 | 772.00 |
| Mar 31, 2023 | 714.00 |
| Dec 31, 2022 | 904.00 |
| Sep 30, 2022 | 708.00 |
| Jun 30, 2022 | 1,339.00 |
| Mar 31, 2022 | 1,620.00 |
| Dec 31, 2021 | 1,935.00 |
| Sep 30, 2021 | 6,669.00 |
| Jun 30, 2021 | 1,814.00 |
| Mar 31, 2021 | 1,743.00 |
| Dec 31, 2020 | 767.00 |
| Sep 30, 2020 | 1,776.00 |
| Jun 30, 2020 | 1,922.00 |
| Mar 31, 2020 | 2,851.00 |
| Dec 31, 2019 | 1,906.00 |
| Sep 30, 2019 | 2,101.00 |
| Jun 30, 2019 | 1,989.00 |
| Mar 31, 2019 | 3,979.00 |
| Dec 31, 2018 | 4,291.00 |
| Sep 30, 2018 | 1,454.00 |
| Jun 30, 2018 | 3,687.00 |
| Mar 31, 2018 | 443.00 |